This hypothesis is consistent with the increased nuclear TIAM1 we observed in late-stage NSCLC tumors, the negative association existing between protocadherin expression and survival of NSCLC patients, and the inverse correlation of nuclear TIAM1 with E-cadherin expression in NSCLC patients. The gene discussed is PCDH11X; the disease is non-small cell lung carcinoma.